SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-247799
Filing Date
2021-08-16
Accepted
2021-08-16 16:31:25
Documents
17
Period of Report
2021-08-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d196126d8k.htm   iXBRL 8-K 33113
2 EX-1.1 d196126dex11.htm EX-1.1 231122
3 EX-5.1 d196126dex51.htm EX-5.1 10343
4 EX-99.1 d196126dex991.htm EX-99.1 9893
8 GRAPHIC g196126dsp58.jpg GRAPHIC 5017
9 GRAPHIC g196126g0814041303533.jpg GRAPHIC 2972
  Complete submission text file 0001193125-21-247799.txt   491222

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA clvs-20210816.xsd EX-101.SCH 2909
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE clvs-20210816_lab.xml EX-101.LAB 18138
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clvs-20210816_pre.xml EX-101.PRE 11419
10 EXTRACTED XBRL INSTANCE DOCUMENT d196126d8k_htm.xml XML 3356
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35347 | Film No.: 211178877
SIC: 2834 Pharmaceutical Preparations